HUMULIN 30/70 (INSULIN HUMAN BIOSYNTH INJ)
Google image searchProduct monograph
Active ingredients
insulin, 30 UNIT/ML
insulin isophane (nph), 70 UNIT/ML
DIN: 00795879
Dosage form(s): SUSPENSION
Route(s) of administration: SUBCUTANEOUS
Schedule: Schedule D
Company: ELI LILLY CANADA INC
Date: 11-DEC-1997
ATC:
- A10 — DRUGS USED IN DIABETES (ATC, ATC/DDD, )
- A10A — INSULINS AND ANALOGUES (ATC, ATC/DDD)
- A10AD — Insulins and analogues for injection, intermediate-acting combined with fast-acting (ATC, ATC/DDD)
- A10AD01 — INSULIN (HUMAN) (ATC/DDD)
Pharmaceutical standard: MFR
External Links for Humulin 30/70 (Insulin Human Biosynth Inj)
Search on Google
- Humulin 30/70 (Insulin Human Biosynth Inj) side effects
- Humulin 30/70 (Insulin Human Biosynth Inj) dosage
- insulin side effects
- insulin dosage
- insulin isophane side effects
- insulin isophane dosage
Eli Lilly Canada Inc
Go to Eli Lilly website to see drug product details. Sometimes you can find humulin 30/70 (insulin human biosynth inj) photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.